RFRita Favas

Rita Favas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rita Favas has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quality-by-design in the scale-up of lipid-based nanocarrier formulations: a review

    by Rita Favas, Hugo Almeida, Andreia F. Peixoto, Domingos Ferreira, Ana C. Silva

  • Marine bioactive compounds: Sustainable sources, green extraction, and healthcare applications

    by Rita Favas, Marta Monteiro, Hugo Almeida, Domingos Ferreira, Andreia Filipa Peixoto, Ana Catarina Silva


  • Open Access

    Advances in Encapsulating Marine Bioactive Compounds Using Nanostructured Lipid Carriers (NLCs) and Solid Lipid Nanoparticles (SLNs) for Health Applications

    by Rita Favas, Hugo Almeida, Andreia F. Peixoto, Domingos Ferreira, Ana C. Silva

    As life expectancy rises and modern lifestyles improve, there is an increasing focus on health, disease prevention, and enhancing physical appearance. Consumers are more aware of the benefits of natural ingredients in healthcare products while also being mindful of sustainability challenges. Consequently, marine bioactive compounds have gained popularity as ingredients in cosmetics and food supplements due to their diverse beneficial properties. Nonetheless, the use of some of these compounds is restricted by their low stability and poor aqueous solubility, necessitating solutions to overcome these limitations. In this context, lipid nanoparticles, such as solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), have been investigated for their potential to protect and improve the absorption of molecules through various routes, including oral and cutaneous. Numerous studies have shown that nanoencapsulating these compounds and incorporating them into cosmetics and food supplements can be effective. However, this application remains unregulated at the global level and is not currently addressed by existing legislation. Additional in vivo studies in both animals and humans are necessary to fully assess safety concerns.


  • Open Access

    Advances in Encapsulating Marine Bioactive Compounds Using Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN) for Health Applications

    by Rita Favas, Hugo Almeida, Andreia F. Peixoto, Domingos Carvalho Ferreira, Ana Catarina Silva

    With increased life expectancy and improved modern lifestyles, there has been a growing concern for health, including the prevention of disease and the improvement of physical appearance. Consumers are increasingly aware of the benefits of using natural ingredients in healthcare products and at the same time are concerned about the challenges of sustainability. In this sense, the use of marine bioactive compounds as cosmetic ingredients and in food supplements has become increasingly popular due to the benefits derived from their various properties. However, some of these compounds have limited use, mainly due to their low stability and poor aqueous solubility, and solutions need to be developed to overcome these limitations. In this sense, the use of lipid nanoparticles, such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), has been explored as these carriers show ability to protect and enhance the absorption of molecules. Several studies have demonstrated the efficacy of encapsulating these compounds and incorporating them into cosmetics and food supplements. However, there is still no global legislation and safety concerns have been raised. Further clinical studies in animals and humans are needed to clarify safety issues.


  • Open Access

    Cyanobacteria Secondary Metabolites as Biotechnological Ingredients in Natural Anti-Aging Cosmetics: Potential to Overcome Hyperpigmentation, Loss of Skin Density and UV Radiation-Deleterious Effects

    by Rita Favas, Janaína Morone, Rosário Martins, Vitor Vasconcelos, Graciliana Lopes

    The loss of density and elasticity, the appearance of wrinkles and hyperpigmentation are among the first noticeable signs of skin aging. Beyond UV radiation and oxidative stress, matrix metalloproteinases (MMPs) assume a preponderant role in the process, since their deregulation results in the degradation of most extracellular matrix components. In this survey, four cyanobacteria strains were explored for their capacity to produce secondary metabolites with biotechnological potential for use in anti-aging formulations. Leptolyngbya boryana LEGE 15486 and Cephalothrix lacustris LEGE 15493 from freshwater ecosystems, and Leptolyngbya cf. ectocarpi LEGE 11479 and Nodosilinea nodulosa LEGE 06104 from marine habitats were sequentially extracted with acetone and water, and extracts were analyzed for their toxicity in cell lines with key roles in the skin context (HaCAT, 3T3L1, and hCMEC). The non-toxic extracts were chemically characterized in terms of proteins, carotenoids, phenols, and chlorophyll a, and their anti-aging potential was explored through their ability to scavenge the physiological free radical superoxide anion radical (O2•−), to reduce the activity of the MMPs elastase and hyaluronidase, to inhibit tyrosinase and thus avoid melanin production, and to block UV-B radiation (sun protection factor, SPF). Leptolyngbya species stood out for anti-aging purposes: L. boryana LEGE 15486 presented a remarkable SPF of 19 (at 200 µg/mL), being among the best species regarding O2•− scavenging, (IC50 = 99.50 µg/mL) and also being able to inhibit tyrosinase (IC25 = 784 µg/mL), proving to be promising against UV-induced skin-aging; L. ectocarpi LEGE 11479 was more efficient in inhibiting MMPs (hyaluronidase, IC50 = 863 µg/mL; elastase, IC50 = 391 µg/mL), thus being the choice to retard dermal density loss. Principal component analysis (PCA) of the data allowed the grouping of extracts into three groups, according to their chemical composition; the correlation of carotenoids and chlorophyll a with MMPs activity (p < 0.01), O2•− scavenging with phenolic compounds (p < 0.01), and phycocyanin and allophycocyanin with SPF, pointing to these compounds in particular as responsible for UV-B blockage. This original survey explores, for the first time, the biotechnological potential of these cyanobacteria strains in the field of skin aging, demonstrating the promising, innovative, and multifactorial nature of these microorganisms.